Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The neuroleptic malignant syndrome. A priority system.

V M Neppe

    South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
    |March 31, 1984
    PubMed
    Summary

    Neuroleptic malignant syndrome (NMS) is a rare but life-threatening reaction to neuroleptic drugs, characterized by fever, muscle rigidity, and altered consciousness. Early recognition and treatment are crucial for patient survival.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dysproccia: a necessary new term for impaired higher brain processing.

    The Journal of neuropsychiatry and clinical neurosciences·2001
    Same author

    Buspirone in the treatment of tardive dyskinesia.

    Journal of clinical psychopharmacology·1993
    Same author

    Capgras' syndrome of self.

    The Journal of neuropsychiatry and clinical neurosciences·1992
    Same author

    Carbamazepine for atypical psychosis with episodic hostility.

    The Journal of nervous and mental disease·1991
    Same author

    The use of carbamazepine to treat benzodiazepine withdrawal in a geriatric population.

    Journal of geriatric psychiatry and neurology·1991
    Same author

    Carbamazepine for high-dose diazepam withdrawal in opiate users.

    The Journal of nervous and mental disease·1991

    Area of Science:

    • Neurology
    • Pharmacology
    • Critical Care Medicine

    Background:

    • Neuroleptic malignant syndrome (NMS) is a severe adverse reaction associated with neuroleptic medications.
    • It presents with a distinct clinical triad of hyperthermia, muscle rigidity, and autonomic dysfunction, alongside altered mental status.
    • NMS shares clinical similarities with other hyperthermic syndromes, notably malignant hyperthermia, necessitating careful differential diagnosis.

    Purpose of the Study:

    • To summarize the key features of neuroleptic malignant syndrome.
    • To highlight the importance of early diagnosis and management of NMS.
    • To discuss potential therapeutic interventions for NMS.

    Main Methods:

    • Review of existing literature on neuroleptic malignant syndrome.
    • Analysis of clinical presentation, pathophysiology, and treatment options.
    • Comparison with similar clinical conditions like malignant hyperthermia.

    Main Results:

    • NMS is a potentially lethal condition requiring prompt recognition.
    • The syndrome is linked to dopaminergic system dysregulation in the hypothalamus and basal ganglia.
    • While no specific antidote exists, several treatments have shown efficacy.

    Conclusions:

    • Neuroleptic malignant syndrome is a critical medical emergency.
    • Understanding its pathophysiology aids in diagnosis and management.
    • Successful treatment may involve agents such as dantrolene sodium, bromocriptine, amantadine, and phenytoin.

    Related Experiment Videos